Skip to main content

Advertisement

Table 2 Evaluation of the impact of MHR on ischemic stroke by multivariate logistic regression models

From: Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: insights from a population-based Chinese cohort

Variables Odds Ratio (95% CI)
Crude P value Model 1 P value Model 2 P value
MHR (Per 1 SD increase) 1.426 (1.221, 1.666) <0.001 1.375 (1.170, 1.615) <0.001 1.276 (1.082, 1.504) 0.004
Quartiles of MHR
 Quartile 1 1.000 (reference)   1.000 (reference)   1.000 (reference)  
 Quartile 2 1.314 (0.831, 2.076) 0.243 1.206 (0.756, 1.925) 0.432 1.155 (0.720, 1.851) 0.550
 Quartile 3 1.434 (0.915, 2.248) 0.116 1.393 (0.880, 2.207) 0.157 1.257 (0.788, 2.005) 0.338
 Quartile 4 2.186 (1.440, 3.319) <0.001 1.924 (1.252, 2.956) 0.003 1.624 (1.045, 2.524) 0.031
 P for trend   <0.001   0.001   0.024
  1. Abbreviations: MHR monocyte count to high-density lipoprotein cholesterol ratio, OR odds ratio; 95% CI: 95% confidence interval, SD standard deviation. Other abbreviations as in Table 1
  2. Crude: no adjustment; Model 1: adjusted for age, sex, race, education level, family annual income level, physical activity, current smoking, current drinking, and diet score; Model 2: adjusted for all the factors in model 1 and serum creatinine, systolic blood pressure, fasting plasma glucose, body mass index, and lipid-lowering drug
  3. Quartile 1: MHR < 0.229; Quartile 2: 0.229 ≤ MHR < 0.341; Quartile 3: 0.341 ≤ MHR < 0.485; Quartile 4: MHR ≥ 0.485